“…After the discovery, precision on the measurement of this new particle properties and interactions has progressed as more data were collected. Currently, all production processes have been observed in one or more decay channels or via combination of several decay channels, with no significant deviations with respect to the SM prediction. …”
Enlace del recurso

“…We also searched the WHO International Clinical Trials Registry Platform and ClinicalTrials.gov for trials in progress. SELECTION CRITERIA: For the RCT review and the narrative review, any therapeutic for the treatment of mpox in humans was eligible for inclusion, including tecovirimat, brincidofovir, cidofovir, NIOCH‐14, immunomodulators, and vaccine immune globulin. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…The non-steroidal anti-inflammatory drugs used in the treatment of RA do not fully control the progression of joint inflammation and bone destruction and have notable adverse reactions. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Quarante-trois (80%) soignants estimaient positive l'ouverture du SI-SMIT en terme de nouvelles compétences et de progression. Etude 2: Parmi les 64 services ayant répondu (soit 85% de réponses), 5 disposaient déjà de SI sous la responsabilité d'infectiologues avant la pandémie et 7 services ont ouvert une unité de SI-SMIT. …”
Enlace del recurso
Enlace del recurso

“…This research, when well-conducted, will be key to making progress in the clinical management of RIF. STUDY FUNDING/COMPETING INTEREST(S): The meetings and technical support for this project were funded by ESHRE. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Background: Diabetic nephropathy (DN) is the main cause of chronic kidney disease (CKD) and end-stage renal failure (ESRF), and the control of disease progression and adverse events during treatment needs to be improved. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…In March 2007, the FDA changed the labeling of the ESAs to add boxed warnings, updated in November 2007, to include the following key points: (a) ESAs should be used only to treat anemia that occurs in patients with cancer while they are undergoing chemotherapy; (b) treatment with ESAs should be stopped when chemotherapy ends; and (c) dosing ESAs to an Hb target of 12 gm per dL or greater has resulted in more rapid cancer progression or shortened overall survival in patients with breast, head and neck, lymphoid, cervical, and non-small cell lung malignancies. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…In our patient’s case, progress was only possible when all three parties involved in her care felt safe to proceed. …”
Enlace del recurso
Enlace del recurso

“…Methods: Pts met all following criteria: ≥18 yrs, TED 2-10 yrs, inactive disease or >1 yr without progression in proptosis/diplopia/new symptoms, baseline (BL) CAS≤1, increased proptosis ≥3mm before TED or from normal, euthyroid/mildly hypo/hyperthyroid, no prior teprotumumab and no steroids within 3 wks of screen. …”
Enlace del recurso
Enlace del recurso

“…We extracted and analyzed progression-free survival (PFS) and overall survival (OS). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…A novel biomarker, pan-immune-inflammation value (PIV) or called the aggregate index of systemic inflammation (AISI), linked to progression-free survival and overall survival in non-small-cell lung cancer and mortality in Coronavirus Disease 2019 (COVID-19) patients, has surfaced recently. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…CONCLUSION: ZLJT has potential antitumor progression effects. For patients with EGFR gene-mutated non-small cell LUAD, combining ZLJT with EGFR-TKI treatment can delay the occurrence of acquired resistance. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…We performed the present study to ask if the presence of autoantibodies to p53 has any association with breast cancer progression. MATERIALS AND METHOD: A library of plasma samples were collected from all patients attending one general oncology clinic for postoperative follow up of breast cancer. …”
Enlace del recurso
Enlace del recurso

“…A careful study of the progress of the disease in man together with the behavior of the organism in the monkey and the goat would suggest, at least, that the function of toxin production is, after all, of little use to the leprosy bacillus because it has seemingly acquired a highly parasitic existence; instead of which it is not only possible, but highly probable, that its defensive protection, whatever it may be, is enormously developed. …”
Enlace del recurso
Enlace del recurso

“…The animal develops a rapidly progressing bacteriemia and dies. 2. Passively Immunised Normal Rabbits.…”
Enlace del recurso
Enlace del recurso

“…At this time the tissues are not sensitive, but as antigen absorption progresses and the tissues are stimulated to react, sensitiveness develops, which renders them much more delicately amenable to injury by direct reaction with even small amounts of dissolved but otherwise unaltered antigen. …”
Enlace del recurso
Enlace del recurso

“…If this phenomenon were to take place also in the infected body injected with these drugs, it is obvious that in a rapidly evolving infectious disease like yellow fever the progress of the infection will be too rapid to allow the drugs to exert their beneficial effect upon the course of the disease. …”
Enlace del recurso
Enlace del recurso

“…Recently, there has been significant progress in our knowledge of the factors controlling these events, in particular the generation and regulation of calcium signals. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Quantitative results obtained from the proposed methodology were visually related to the progress and severity of the pulmonary infections as verified by the participating radiologists. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…In brief, clinical evidence shows the kidney protective potential of erythropoietin in patients with chronic renal failure, however, additional clinical investigations are crucial to outline when to start erythropoietin treatment and what is the optimal erythropoietin dosage for slowing disease progression in patients with chronic renal failure. …”
Enlace del recurso
Enlace del recurso